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Abstract
Background: Sarcoidosis is a systemic disease of unknown etiology, in which granulomas develop in various
organs, including the skin, lungs, eyes, or heart. It has been reported that patients with sarcoidosis are more likely
to develop panic disorder than members of the general population. However, there are many unknown factors
concerning the causal relationship between these conditions.
Case presentation: We present the case of a 57-year-old woman who appeared to have panic disorder, as she
experienced repeated panic attacks induced by transient complete atrioventricular block, associated with cardiac
sarcoidosis. Psychotherapy and pharmacotherapy were not effective in the treatment of her panic attacks. However,
when we implanted a permanent pacemaker and initiated steroid treatment for cardiac sarcoidosis, panic attacks
were ameliorated. Based on these findings, we diagnosed the patient’s symptoms as an anxiety disorder associated
with cardiac sarcoidosis, rather than panic disorder.
Conclusions: This report highlights the importance of considering cardiac sarcoidosis in the differential diagnosis of
panic disorder. This cardiac disease should be considered especially in patients have a history of cardiac disease (e.g.,
arrhythmia) and atypical presentations of panic symptoms. Panic disorder is a psychiatric condition that is typically
diagnosed after other medical conditions have been excluded. Because the diagnosis of sarcoidosis is difficult in some
patients, caution is required. The palpitations and symptoms of heart failure associated with cardiac sarcoidosis can be
misdiagnosed as psychiatric symptoms of panic disorder. The condition described in the current case study appears to
constitute a physical disease, the diagnosis of which requires significant consideration and caution.
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Background
Panic disorder is characterized by repeated panic attacks
and anticipatory anxiety concerning these attacks [1].
Importantly, exclusion of other physical diseases is re-
quired for a diagnosis of panic disorder [1]. Because
panic attacks may be caused by physical diseases, such
as hyperthyroidism, brain tumors, or arrhythmias, panic
disorder should be diagnosed with caution [1].
Sarcoidosis is a systemic disease of unknown etiology
in which granulomas develop in various organs (e.g., the
skin, lungs, eyes, or heart) [2]. Cardiac lesions are specif-
ically referred to as cardiac sarcoidosis, a condition that
can lead to fatal arrhythmias or heart failure [2]. It has
been reported that 44% of patients with sarcoidosis ex-
perience comorbid psychiatric disorders, with panic dis-
order observed in 6.3% of cases [3]. The prevalence of
panic disorder among patients with sarcoidosis is higher
than that of the 2.7% reported in the general population
[4]. However, many aspects of the causal relationship
between these conditions are currently unknown.
Case presentation
We present the case of a 57-year-old woman. The pa-
tient visited our emergency room because of sudden pal-
pitations and dyspnea. Physical examination revealed
stable and sustained ventricular tachycardia. However,
ventricular tachycardia returned spontaneously to a
normal sinus rhythm. After admission to the cardiology
ward, further examinations, including left heart
catheterization, were performed. However, the cause of
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ventricular tachycardia remained unclear. Following dis-
charge, the patient experienced palpitations and dyspnea
approximately once a month. Therefore, we repeatedly
performed a 12-lead electrocardiogram, a 24-h ambula-
tory electrocardiogram, hematologic examinations, and
chest radiography. These examinations revealed no clear
abnormalities that could explain the palpitations. It was
suspected that the patient’s physical symptoms were due
to a psychiatric condition. Thus, one and a half years
after her initial visit to the cardiology ward, she was re-
ferred to the department of neuropsychiatry. The patient
experienced palpitations and dyspnea at rest without any
apparent cause. These symptoms sometimes continued
for two to three hours. During each incident, the patient
experienced a strong fear of dying. She also experienced
strong anticipatory anxiety and left her house less fre-
quently than she used to because of the fear that palpita-
tions would occur. Hematologic findings revealed that
the patient’s thyroid hormone levels were within the nor-
mal range. Furthermore, cranial computed tomography
findings indicated no clear abnormalities. Because no
structural abnormalities were noted and the patient was
experiencing repeated panic attacks, we diagnosed her
symptoms as panic disorder. After assuring the patient
that panic attacks are not fatal, we attempted cognitive
behavioral therapy and pharmacotherapy (alprazolam
1.2 mg/day and mirtazapine 15 mg/day). However, the
panic attacks continued. The frequency of panic attack
symptoms progressively worsened until she experienced
daily panic attacks. Approximately 2 months after her
initial visit to the department of neuropsychiatry, a 24-h
ambulatory electrocardiogram revealed cardiac pause
(maximal 32 s) due to a complete atrioventricular block,
and transient sinus tachycardia following recovery from
the pause (Fig. 1). Moreover, the onset of panic attack
symptoms was consistent with these electrocardiographic
abnormalities. Therefore, a permanent pacemaker was im-
planted. Following implantation of the permanent pace-
maker, the frequency of the panic attacks improved, and
anticipatory anxiety and fear of death disappeared. How-
ever, 1 month after implantation of the permanent pace-
maker, the patient was brought to our hospital’s
emergency department with symptoms of heart failure.
Echocardiographic findings revealed a decrease in left ven-
tricular systolic function (ejection fraction 40%) and basal
thinning of the interventricular septum. Thus, cardiac sar-
coidosis was suspected. Serum angiotensin-converting en-
zyme and soluble interleukin-2 receptor levels were within
reference ranges, but gallium scintigraphy revealed signifi-
cant gallium uptake in the heart. We did not perform a
myocardial biopsy because of the risk of cardiac perfor-
ation, cardiac tamponade and dislodging the pacemaker
leads. Based on the diagnostic criteria for cardiac sarcoid-
osis [5], we made a clinical diagnosis of cardiac sarcoid-
osis. Other clinical findings suggested that the patient also
had concomitant pulmonary sarcoidosis, as extracardiac
sarcoidosis. Chest X-ray findings did not reveal any clear
bilateral hilar lymphadenopathy, but a chest computed
tomography scan revealed multiple nodular shadows sug-
gestive of sarcoid granulomas. Furthermore, gallium scin-
tigraphy revealed significant gallium uptake in the lung.
No findings suggestive of skin manifestations of sarcoid-
osis or neurosarcoidosis were observed. We started steroid
therapy (prednisolone 30 mg/day), and the patient’s car-
diac function and gallium scintigraphic abnormalities were
ameliorated. This improvement indicated that the cause
of complete atrioventricular block was associated with car-
diac sarcoidosis. Therefore, the set of symptoms that were
initially attributed to panic disorder were actually caused
by a complete atrioventricular block associated with car-
diac sarcoidosis, which secondarily caused panic attacks.
The patient was subsequently diagnosed with an anxiety
Fig. 1 The onset of panic attack symptoms was consistent with electrocardiographic abnormalities. A 24-h ambulatory electrocardiogram revealed
cardiac pause (maximal 32 s) due to a complete atrioventricular block, and transient sinus tachycardia following recovery from the pause. The
onset of panic attack symptoms was consistent with these electrocardiographic abnormalities
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disorder associated with cardiac sarcoidosis, rather than
panic disorder.
Discussion
In the case described in this report, differentiating car-
diac sarcoidosis from panic disorder was difficult. Ac-
cording to the DSM-5, the diagnosis of panic disorder is
applied in cases of repeated and unexpected panic at-
tacks, where the condition is defined as not being caused
by the physiological effect of a substance or other
medical condition (e.g., hyperthyroidism or a cardiopul-
monary disorder) [1]. Panic attacks are psychiatric symp-
toms in which sudden severe fear or discomfort
increases and peaks within a few minutes, and four of 13
symptoms (palpitations, sweating, trembling, sensations
of shortness of breath, feelings of choking, chest pain,
nausea, dizziness, chills, paresthesia, derealization, fear
of losing control, or fear of dying) occur during that
time [1]. In the case described in the current report, the
patient exhibited palpitations, dyspnea, chest pain, and
fear of death. Furthermore, the patient experienced an-
ticipatory anxiety of panic attacks, and because of the
fear of future attacks, the frequency with which she was
able to leave her house decreased. Although the patient
had a history of one episode of ventricular tachycardia,
an outpatient cardiovascular examination revealed no
structural abnormalities to explain the repeated palpita-
tions, and the patient was referred to the department of
psychiatry. The examination indicated that the patient’s
thyroid function was normal, and no other structural ab-
normalities were noted at the initial visit. Therefore, we
assumed that the palpitations were due to panic dis-
order. Thus, we initiated psychotherapy and the admin-
istration of psychotropic medication, but observed no
therapeutic effects. During the clinical course, it became
clear that the cause of panic attacks was complete atrio-
ventricular block associated with cardiac sarcoidosis and
transient sinus tachycardia following recovery from the
cardiac pause. Because the attacks were not frequent
and occurred approximately once a month, it was diffi-
cult to detect the electrocardiographic abnormalities
using a 24-h ambulatory electrocardiogram, which may
have contributed to the delay in the diagnosis. To per-
form an accurate diagnosis earlier, it may have been use-
ful to use an implantable loop recorder to analyze
electrocardiographic findings during attacks [6]. Al-
though our patient was inserted a permanent pacemaker
to treat complete atrioventricular block, it was initially
not possible to diagnose her with cardiac sarcoidosis.
Furthermore, ventricular tachycardia was only noted
once during the initial presentation, and its relationship
with the subsequent cardiac sarcoidosis was unclear.
However, considered retrospectively, the ventricular
tachycardia and complete atrioventricular block might
have appeared as a series of symptoms caused by cardiac
sarcoidosis. When a treatment plan is determined, im-
plantation of a dual chamber pacemaker/defibrillator
should be considered to treat recurrence of ventricular
tachycardia [7, 8]. However, the possibility of depression,
anxiety, or other emotional impact that could result
from ICD implantation should also be considered [9],
especially because our patient had a history of panic at-
tacks and anxiety disorder. We suggest that sufficient
patient-physician communication is important before
ICD implantation [9].
An increasing number of recent studies have reported
a relationship between sarcoidosis and psychiatric disor-
ders. In the general population, the prevalence rate of
panic disorder is reportedly 2.7% [4]. By contrast,
Goracci et al. reported that 6.3% of patients with sar-
coidosis also exhibit panic disorder, and 25% of patients
with cardiac sarcoidosis also have depression, while 5%
also have an anxiety disorder [3]. A possible relationship
between the decrease in respiratory function and psychi-
atric symptoms (e.g., anxiety disorder and depressive dis-
orders) has been suggested [3]. But there are many
unknown factors concerning the causal relationship
between the conditions. Psychiatric manifestations, in-
cluding apathy, delirium and depression, occur in about
20% of patients with neurosarcoidosis, reflecting the po-
tential for granulomatous infiltration of any part of the
central nervous system [10]. In a study examining parox-
ysmal supraventricular tachycardia, Colucci et al. noted
that some patients receiving a delayed diagnosis of
arrhythmia are initially misdiagnosed as having panic
disorder [11]. As observed in the present case, it is pos-
sible for patients with arrhythmia associated with cardiac
sarcoidosis causing panic attacks in whom physical dis-
eases have been overlooked to be misdiagnosed with
panic disorder. However, no previous reports have
highlighted the importance of differentiating cardiac sar-
coidosis from panic disorder.
In cases of cardiac sarcoidosis, in conjunction with the
progression of the disease, clinical symptoms, such as
dizziness, syncope, palpitations, and dyspnea, are typic-
ally observed due to cardiac dysfunction. However,
because these symptoms are nonspecific and the pro-
gression of the disease is slow, diagnosis is often delayed.
According to autopsy reports of patients with sarcoid-
osis, cardiac involvement is present in at least 27% of
cases [12], but cardiac sarcoidosis is clinically observed
in only 5% of patients [13]. This finding indicates that
many cardiac lesions are overlooked ante mortem [2, 14].
In our case, echocardiography revealed basal thinning of
the interventricular septum, a characteristic feature of car-
diac sarcoidosis, which served as the steppingstone that
led to the accurate diagnosis of this condition [15, 16].
Thus, echocardiography should be considered in patients
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who develop new-onset panic attacks at an older age as
panic disorder or in individuals with a history of arrhyth-
mias or other cardiac problems that could lead to panic-
like symptoms.
Although sarcoidosis spontaneously subsides over time
in some patients, caution is required, as fatal cases of
arrhythmia and severe heart failure may develop in pa-
tients with cardiac involvement. Histological diagnosis of
cardiac sarcoidosis requires myocardial biopsy, but
diagnostic sensitivity is low (19.2%) [17]. Thus, it is
necessary to consider early steroid treatment based
on the clinical diagnosis when cardiac sarcoidosis is
clinically suspected [18, 19].
Because panic disorder is a psychiatric disorder in
which diagnosis is contingent on excluding other phys-
ical symptoms, in the case of indolent diseases, accurate
differentiation during the initial stages of the disorder is
difficult. Therefore, it is important to differentiate phys-
ical diseases when psychiatric treatment initiated under
the diagnosis of panic disorder is ineffective.
Conclusions
The current case report highlights the importance of
considering cardiac sarcoidosis in the differential diagno-
sis of panic disorder. This cardiac disease should be con-
sidered especially the patients have a history of cardiac
disease (e.g., arrhythmia) and atypical presentations of
panic symptoms.
Panic disorder is a psychiatric disorder that is diag-
nosed after other medical conditions have been ex-
cluded. Because differentiation is difficult in some
patients, caution is required. Moreover, it is possible for
palpitations and heart failure symptoms associated with
cardiac sarcoidosis to be misdiagnosed as psychiatric
symptoms of panic disorder. Therefore, the condition
described in the present report appears to constitute a
physical disease for which caution is required in psychi-
atric diagnosis.
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